EULAR has released recommendations to enable health professionals to provide knowledgeable pain management support for patients with inflammatory arthritis and osteoarthritis.
Patients with RA who were treated in the first 6 months had a lower risk of death.
For every 5 patients with RAs displaying improved disease activity scores or remission by clinical criteria, 2 will exhibit disease progression on MRI.
The first evidence-based recommendations on the use of imaging in osteoarthritis clinical practice have been released by the European League Against Rheumatism.
EULAR recommendations were updated for rheumatoid arthritis management to include new guidelines on starting effective therapy in patients early.
Much of the disability associated with RA relates to the pain secondary to inflammatory joint inflammation.
Clinical Pain Advisor Articles
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Women Frequently Prescribed High Doses of Opioids After Vaginal Delivery
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Electroacupuncture May Help Reduce Opioid Use in Chronic Musculoskeletal Pain
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- Opioid Use Disorder Prevalence at Delivery on the Rise in the US, According to CDC
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Pharmacologically Induced Headache Accompanied by Dilated Cephalic Vessels
- IV Lidocaine May Be Safe, Efficacious for Pediatric Status Migraine
- Gray Matter Changes in Migraine Associated With Clinical Characteristics